Got $1,000? Here Are 2 TSX Stocks to Play the Vaccine Euphoria

Here are two TSX stocks that are trading at considerable discounts but could skyrocket in 2021. Do you own these two Canadian titans?

| More on:

Some TSX stocks have been trading weak recently, dominated by the pandemic’s dreadful second wave. However, favourable developments on the vaccine front suggest a forceful recovery for them, probably in the second half of 2021.

Here are two such TSX stocks that are trading at a considerable discount but could skyrocket next year. So, if you are sitting on some cash, consider these undervalued stocks for massive long-term gains.

BRP

Shares of the powersports vehicle manufacturer BRP (TSX:DOO)(NASDAQ:DOOO) has been on a downtrend trend recently. While the market has been soaring to new heights on the vaccine news, BRP stock has fallen 17% so far in November.

The $6 billion company BRP works in more than 120 countries and is a leader in all-terrain vehicles, snowmobiles, and personal watercraft segments.

I think the stock is oversold and could reach new peaks when it reports quarterly earnings next week. Even though the company posts flattish growth, as the consensus estimates suggest, upbeat management commentary could drive the stock notably higher.

BRP saw a remarkable improvement in demand in the earlier quarter, which could have further taken a hit by the second wave recently. However, things can progress as consumer discretionary spending normalizes in the post-pandemic environment. Interestingly, a sooner vaccine launch could substantially accelerate its recovery in 2021.

BRP stock has more than tripled since its pandemic lows in March. Currently, the stock is facing crucial resistance at $75 levels. It has fallen thrice after touching those levels in the last 12 months.

However, its attractive valuation and upbeat management commentary in the upcoming quarterly release could beat those levels in the next few weeks.

Bank of Nova Scotia

The vaccine news boosted Canadian bank stocks in the last few weeks. But Bank of Nova Scotia (TSX:BNS)(NYSE:BNS) soared almost 20% this month, notably outperforming peers. The outperformance is quite justified, as the vaccine could accelerate Scotiabank’s recovery.

It has a large exposure to Latin American countries — some of the pandemic’s worst-affected areas. BNS stock has lost 16% so far this year.

Interestingly, Scotiabank is among the cheapest of bank stocks from the valuation standpoint, despite its recent rally. The discounted valuation makes it an apt bet for contrarian investors in the current market scenario.

Also, it yields almost 6%, higher than average Canadian bank stocks. Bank of Nova Scotia has paid dividends for the last 187 consecutive years.

The bank will release its fiscal fourth-quarter results early next month. Its upcoming earnings might not significantly decline, as it has already set aside a large chunk in provisions for credit losses.

Scotiabank stock might trade muted in the next few quarters. Investors can enjoy handsome dividends till then. Many analysts see Scotiabank’s Latin American exposure as a risky play.

However, I think the same will act as a growth engine for the bank post-pandemic. Also, its diversified earnings base and strong credit quality should fuel compelling recovery in the long term.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Vineet Kulkarni has no position in any of the stocks mentioned. The Motley Fool recommends BANK OF NOVA SCOTIA.

More on Stocks for Beginners

dividends grow over time
Stocks for Beginners

The Smartest Growth Stock to Buy With $2,000 Right Now

Do you have $2,000 to invest for the long term? These three TSX stocks have and will continue to deliver…

Read more »

The virtual button with the letters AI in a circle hovering above a keyboard, about to be clicked by a cursor.
Tech Stocks

Is OpenText Stock a Buy, Sell, or Hold for 2025?

OpenText stock has fallen in the last few years, but that could mean this top tech stock remains an undervalued…

Read more »

man touches brain to show a good idea
Dividend Stocks

3 No-Brainer REIT Stocks to Buy Right Now for Less Than $200

REITs have long been touted as some of the best dividend stocks out there if you want recurring, strong income.…

Read more »

grow money, wealth build
Dividend Stocks

3 Top High-Yield Stocks to Buy in November

If you want passive income, high yield dividend stocks are the clear choice. These are the best, and safest, out…

Read more »

Stocks for Beginners

Where will Loblaw Stock be in 5 Years?

Want a great food stock that can provide growth and income? Here's why Loblaw stock can offer that and more.

Read more »

A worker overlooks an oil refinery plant.
Dividend Stocks

3 Canadian Infrastructure Stocks to Buy Now

Infrastructure makes up everything we use, from the water we drink to the roads we drive. And these three infra…

Read more »

Sliced pumpkin pie
Stocks for Beginners

Ready to Invest With $2,000? 4 Stocks for November

Got $2,000 to start a new investment portfolio? Try these four high quality Canadian stocks for long-term wealth compounding.

Read more »

cloud computing
Tech Stocks

3 No-Brainer Tech Stocks to Buy Right Now for Less Than $1,000

Not all tech stocks are the risky investments that many think they are. Which is why we're focusing on the…

Read more »